# Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

> **NCT07721467** · PHASE2 · RECRUITING · sponsor: **National Institute on Aging (NIA)** · enrollment: 200 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Psilocybin
- **OTHER:** Cognitive Training

## Key facts

- **NCT ID:** NCT07721467
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-14
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721467, "Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*